Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.48
2.19
NAV
₹36.89
₹44.45
Fund Started
20 Jun 2019
25 Jun 2018
Fund Size
₹900.87 Cr
₹6668.95 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
10.63%
5.68%
3 Year
23.31%
26.25%
5 Year
12.61%
15.27%
Equity
98.61%
96.76%
Cash
1.39%
3.24%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.17% |
Apollo Hospitals Enterprise Ltd. | 7.20% |
Torrent Pharmaceuticals Ltd. | 4.76% |
JB Chemicals & Pharmaceuticals Ltd. | 4.71% |
Aurobindo Pharma Ltd. | 4.49% |
Ajanta Pharma Ltd. | 4.05% |
Lupin Ltd. | 4.00% |
Mankind Pharma Ltd. | 3.88% |
Fortis Healthcare Ltd. | 3.87% |
Abbott India Ltd. | 3.65% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Jun 2019
25 Jun 2018
